Cerebral Palsy Flashcards

1
Q

What is CP?

A

group of permanent disorders that affect development of posture and movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CP leads to —— limitations that are the result of

A

activity limitations that come from non progressive brain disturbances on brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BEFORE 5 months use these tools to diagnose CP

A

GMA > Hine > MRI
most to least sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AFTER 6 months use these diagnostic tools

A

Hine and MRI ( 90%)
developmental assessment
don’t use GMA after 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 tool used for diagnosis of CP

A

GMA, HINE, MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Dyskinesia

A

uncontrolled and involuntary movements
includes athetosis, rigidity and tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Athetosis ? 4 long characterisitcs

A
  1. abnormal timing, direction and spatial characteristics
  2. impaired postural stability
  3. abnormal coordination in reversal of movement and latency of onset of movement
  4. oral-motor dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Athetosis impact on MSK system?

A
  1. joints may be hypermobile
  2. significant asymmetry
  3. frequent TMJ issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which tool best has the best combination of sensitivity and specificity for predicting CP in the EARLY months

A

Prechtl’s Assessment of General Movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

These 2 tools diagnose the CP as infants age

A

AIMS and NSMDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the one of the most common MSK abnormalities children with CP present?

A

hypertonicity or spasticity 75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ataxia MSK implications

A
  1. rely on ligaments for balance
  2. rely on vision for balance
  3. Postural insecurity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hypotonia- which is favored fl or ext. ?

A

extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypotonia MSK implications

A
  1. stability gained through end range
  2. contractures
  3. rib cage at risk to become flat ( decreased resting tone + gravity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

muscles at risk for contracture

A

shoulder adductors, elbow, wrist and finger flexors,
hip flexors and adductors, knee flexors, ankle plantarflexors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Key predictors of reduced life expectancy- 2 things

A
  1. lack of mobility
  2. difficulty feeding
17
Q

By what age will 90% of children with CP reach motor potential for LEVEL 5

A

3 years old

18
Q

By what age will 90% of motor potential reached
LEVEL 1

A

5 years old

19
Q

Poor prognosis for ambulation- 2 things

A

rigidity,
persistent tonic neck reflexes

20
Q
  • 3 reasons for subluxation in hip
A
  1. lack of changes in the neonatal hip( too great an angle of inclination, shallow acetabulum)
  2. lack of LE weight bearing in multiple positions
  3. muscle imbalance (hip adductors more active than abductors, contracture of hip flexor)
21
Q

** children at risk for hip dysplasia need to do this

A
  1. stand in abduction (15-30 degrees) and neutral hip flexion
  2. Maintain excellent biomechanical alignment especially of head and spine
22
Q

GMFCS 2
dosage
when to use stander
type of stander

A

when:
9-12 months until onset of indep ambulation
7-8 or when ROM decreases
dosage:
3Xweek for 45 min
Type:
Upright, sit-to-stand or self propelled

23
Q

GMFCS 3
when to use stander
dosage
type

A

when to use: 9-12 through age 5,
7-8 if ROM decreases,
15 if crouch gait appears
dosage: 5 x / week , 60 to 90 mins
type: prone, sit-to-stand or self propelled

24
Q

GMFCS 4 and 5
when to use stander
dosage
type

A

when: 9-12 throughout adulthood
dosage: 5Xweek for 60-90 min/day
Type: prone or supine